Imvax
BioTech/Drugs - Philadelphia, PA, US
Imvax Details
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies. Imvax's combination therapy uniquely captures the complete antigenic signature of a patient's own tumor and converts it into a highly stimulatory ‘training program' for the patient's immune system. The comprehensive nature of this training is intended to result in both innate and adaptive immune stimulation to optimize long-term anti-tumor effects.The company's lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer, with additional programs in other types of solid tumors.
Imvax Technologies
Email Providers
Outlook
CMS
WP Engine
Tag Management
Google Tag Manager
Other
Microsoft Office 365
Hosting
Google Cloud Hosting
CSS and JavaScript Libraries
Bootstrap Framework